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A B S T R A C T   
The introduction of real-time imaging by magnetic resonance guided linear accelerators (MR-Linacs) enabled 
adaptive treatments and gating on the tumor position. Different end-to-end tests monitored the accuracy of our 
MR-Linac during the first year of clinical operation. We report on the stability of these tests covering a static, 
adaptive and gating workflow. Film measurements showed gamma passing rates of 96.4% ± 3.4% for the static 
tests (five measurements) and for the two adaptive tests 98.9% and 99.99%, respectively (criterion 2%/2mm). 
The gated point dose measurements in the breathing phantom were 2.7% lower than in the static phantom.   
1. Introduction 
Magnetic resonance guided radiotherapy (MRgRT) potentially al-
lows smaller margins around the target volume due to real time imaging 
with enhanced soft-tissue contrast [1,2]. The sparing of organs at risk 
may be improved while maintaining a high coverage of the tumor [3]. 
There is the potential to compensate inter- and intra-fractional motion 
by adapting the treatment plan to the actual anatomical situation [4,5] 
and by gating the treatment beam [6,7]. The clinical introduction of 
MRgRT was boosted in the last decade [8–12]. In 2017 the first patient 
was treated on a MR-Linac system, where an MR scanner and a linear 
accelerator (Linac) were combined [13]. The clinical introduction of 
these hybrid systems created new challenges in the quality assurance 
(QA) [14,15], since their overall stability is sensitive to different factors. 
The MR and computer tomography (CT) images need to be registered. 
The MR imaging isocenter must be aligned with the radiation isocenter. 
The electron density map is established from the CT and deformed to 
match the actual MR image. The dose deposition is influenced by the 
magnetic field, which alters the path of the charged secondary particles. 
The radio frequency (RF)-coils of the MR system need to be correctly 
positioned around the patient. MR image quality is crucial for both 
adaptation (image fusion) and irradiation gating (real-time cine 
images). 
Well established QA procedures assess the single steps in the complex 
workflow [16], but uncertainties may accumulate over the treatment 
chain. New phantoms, visible on MR and CT images, were developed 
[14,17,18], but experience on the stability and achievable precision is 
still rare [19,20]. 
Different end-to-end tests were performed to check the complex 
chain of MRgRT. We report on the accuracy of the 6 MV flattening filter 
free (6FFF) Linac in the 0.35 T magnetic field in a static set up, for an 
adaptive and in a gated workflow. The results from film measurements 
of the 2D dose distribution and from point dose measurements are 
presented. The aim of this study was to show the geometric and dosi-
metric stability of our MR-Linac. 
2. Materials and methods 
During the first year of treatment at the MRIdian (Viewray, Oakwood 
Village, OH, USA), the 2D dose distribution and the gating performance 
of the machine were measured alternating every second month. 
2.1. 2D dose distribution 
The first five measurements of the dose distribution were performed 
in a spherical phantom (Lucy 3D QA phantom, Standard Imaging inc., 
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Middleton, Wisconsin, USA). An IMRT plan with 11 beams and a ho-
mogeneously prescribed dose of 2 Gy was irradiated. An MR visible 
insert allowed the registration of the MR images with the CT images. The 
plan was calculated on the MR images, taking the electron densities from 
the registered pretreatment CT into account. For the measurements, the 
spherical phantom was placed on the RF-coil and aligned to the lasers 
before it was moved to the treatment isocenter. An MR scan was used for 
fine adjustments. The dose was measured on a horizontal gafchromic 
EBT3 film (Ashland Global Specialty Chemicals Inc., Covington, Ken-
tucky, USA) (Fig. 1) within the phantom. Afterwards, a film patch was 
irradiated under reference conditions for the absolute dose calibration. 
The film was analyzed 24 h later with the FilmQA software (Ashland 
Global Specialty Chemicals Inc., Covington, Kentucky, USA). The iso-
center from the film was aligned with the isocenter of the TPS (treatment 
planning system) to perform a gamma analysis, applying a criterion of 
2%/2 mm (dose difference with respect to the local dose/distance-to- 
agreement) [21]. No threshold was set on the background dose. The 
uncertainty was determined as the standard deviation of the measure-
ments. After the first five measurements, we started to include the online 
plan adaption. To facilitate the set-up, a new cuboid silicon phantom 
(19 cm × 23 cm × 17 cm, silicon rubber, KauPo, Plankenhorn, Spai-
chingen, Germany) (Fig. 1) was developed. On the central horizontal 
plane a frame for a radiochromic film was integrated, allowing the 
precise positioning of the film. For the adaptive workflow an IMRT plan 
Fig. 1. Set-up for the three different end-to-end tests. On top, the phantoms are shown, first the spherical phantom followed by the in-house made silicon phantom 
and the thorax motion phantom. Below, the characteristics of the static, adaptive and gating measurements are indicated. In the next row the dose distribution in the 
TPS is displayed. Then, the longitudinal measured and planned dose profiles are shown for the static and adaptive tests. For the gating tests the calculated longi-
tudinal dose profile is combined with the point dose measurements. 
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with 11 beams prescribing 3 Gy to the 65% isodose line was calculated. 
The silicon phantom is highly visible in the CT and the MR, which 
makes the deformable registration of the electron density map possible. 
It was placed on the RF-coil, aligned to the lasers and shifted to the 
isocenter, before an MR scan was performed. After matching the actual 
MR images with the reference, the structures of the plan were copied to 
the new MR scan and were adapted to simulate an anatomical change. 
The mean Dice coefficient [22,23] of the original gross tumor volume 
(GTV) and the adapted GTV was 0.55. In a next step a full adaption of the 
plan was performed, where the individual segments of the beams were 
optimized according to the changed GTV before the plan was irradiated. 
The original plan was irradiated as well as the plan which was adapted 
on the real time MR. Both dose distributions were measured and 
compared to the calculated doses (Fig. 1), applying a gamma evaluation 
criterion of 2%/2 mm. 
2.2. Point dose measurements 
The gating performance of the MR-Linac was evaluated in the dy-
namic thorax phantom (CIRS Inc., Norfolk, Virginia, USA) using a 7-field 
IMRT plan (Fig. 1). A dose of 5 Gy was prescribed to the 65% isodose line 
covering the planning target volume (PTV), simulating an SBRT (ste-
reotactic body RT) treatment. The PTV was derived from the GTV by a 
margin expansion of 3 mm. Within these 3 mm the dose dropped from 
6.75 Gy to 5 Gy, corresponding to a dose gradient of 0.58 Gy/mm. A 
microDiamond detector (PTW Freiburg, Freiburg, Germany) was inser-
ted into a target rod moving longitudinally with an amplitude of 7.5 mm 
within a body-like support structure. The amplitude was defined be-
tween the midline and inhale/exhale position of the motion. As a motion 
pattern, a cos4 function with a period of 4 sec was applied. In a first set- 
up, the GTV of 1.2 cm3 was enlarged by 3 mm to define the gating 
window (3 measurements). In a second set- up, a surrogate tracking 
structure was used for gating to simulate an anatomical situation with 
low contrast (4 measurements). The surrogate structure, an insert in the 
phantom, was enlarged by 2 mm. The beam was switched on as long as 
more than 95% of the target was within the gating window. To study the 
effects of breathing, the recorded point doses were compared to the 
measurements in a static phantom and to the dose measured in the 
breathing phantom without applying gating (9 measurements each). A 
positioning uncertainty of 1 mm was assumed. The uncertainties in the 
dose were calculated as the standard deviation of the measurements. 
Since the microDiamond detector was aligned parallel to the magnetic 
field, the effect of the magnetic field on the detector could be neglected 
[24]. 
3. Results 
The gamma evaluation of the five films measuring the non-adapted 
dose distribution in the spherical phantom showed a mean passing 
rate of 96.4% ± 3.4% for a 2%/2 mm criterion. The passing rates of the 
gamma analysis of the films could be enhanced by the use of the new 
cuboid silicon phantom. The evaluation of the first two adapted films 
showed passing rates of 98.9% and 99.99% with a criterion of 2%/2 
mm. 
The point dose measurements performed with simulated breathing 
showed a mean dose reduction of 34% ± 13% if no gating was applied 
compared to the measurements in a static phantom (Fig. 2). If the irra-
diation was gated using a gating window of 3 mm around the GTV, the 
measured dose was reduced by 6.3% ± 2.5%. If a surrogate tracking 
structure with a boundary of 2 mm was used as gating window, the dose 
was reduced by 2.7% ± 3.0%. 
4. Discussion 
The MR-Linac hybrid systems include new hardware solutions and 
calculation algorithms. A careful evaluation of the whole workflow is 
mandatory to guarantee safe treatments. In this report three different 
types of end-to-end tests are presented (Fig. 1). 
The 2D dose distribution showed a high precision of the 6 MV FFF 
beam and the collimation system of the MR-Linac. 
The image registration and the electron density map calculation are 
sensitive steps in adaptive treatments. To test the adaptive workflow an 
in-house made, homogeneous silicon phantom was used in order to have 
MRI signal across the whole phantom. In the presented work the adapted 
dose distribution corresponded with high precision to the calculated 
dose, gamma passing rates of 98.9% and 99.99% with a criterion of 2%/ 
2 mm were achieved. In summary, the 2D dose distributions measured 
by radiographic films in a static phantom showed an excellent agree-
ment with the planned dose distribution. Including all our measure-
ments (spherical phantom and silicon cuboid) a mean gamma passing 
rate of 97.3% ± 3.2% was recorded. The passing rates are consistent 
with those reported in [19] for their MR-Linac (97.3% ± 2.3% for a 
criterion of 2%/2 mm). Due to the cuboid form of the phantom, the set- 
up uncertainty could be reduced compared to the positioning error of 
the spherical phantom, which includes a 3D rotation, that can not be 
corrected by the couch of our MR-Linac. 
The presented tests were performed with an arbitrary target. For 
future studies the phantom should include inhomogeneities that can be 
used both to define the target and test the registration algorithm based 
Fig. 2. Point dose measurements in the static phantom, in the breathing phantom but without gating, in the breathing phantom with a 3 mm gating window around 
the GTV and in the breathing phantom with a 2 mm gating window around a surrogate tracking structure. The red dot in the first column corresponds to the dose in 
the TPS. 
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upon internal structures. 
The gating performance of the system was studied in the moving 
thorax phantom. The gating window influenced the measured dose for 
an inhomogeneous prescription to a small target volume (1.2 cm3). The 
peaked dose distribution of a typical SBRT plan seems broadened by the 
breathing motion. The dose reduction depended on the size of the 
margin around the tracking structure. For a 3 mm margin a dose 
reduction of 6.3% ± 2.5% was recorded. If the gating margin was 2 mm, 
the dose was reduced by 2.7% ± 3% compared to the dose in a static 
phantom. Depending on the speed of motion and the latency of the 
system, the margin of the gating window, the size of the target volume 
and the planned dose gradient, a dose reduction has to be taken into 
account. In this study point dose measurements were performed in the 
moving phantom, but also 2D measurements of the dose distribution in 
the moving phantom would be interesting. [20] compared the dose 
distribution by film measurements for static and gated treatments on 
their MR-Linac. Gamma passing rates above 95% for a criterion of 4%/3 
mm were reported for a gating window margin of 3 mm while allowing 
10% of the target outside the gating boundary. 
In conclusion, the three different types of end-to-end tests demon-
strated a high geometric and dosimetric accuracy of our MR-Linac 
throughout the first year of treatment, which allows for precise stereo-
tactic body treatments, accurate gating for moving targets and reliable 
adaption of the treatment plan. 
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